The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
boston biomedical | 22 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
a novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors | 91 | 2007 |
naphthofuran compounds and compositions for targeting cancer stem cells | 77 | 2010 |
methods for treating cancer | 45 | 2015 |
composition of asymmetric rna duplex as microrna mimetic or inhibitor | 31 | 2007 |
compositions of kinase inhibitors and their use for treatment of cancer and other diseas… 🛈 | 30 | 2007 |
3-(aryl or heteroaryl) methyleneindolin-2-one derivatives as inhibitors of cancer stem c… 🛈 | 20 | 2013 |
enabling the use of long dsrna for gene targeting in mammalian and other selected animal… 🛈 | 18 | 2007 |
2-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancer | 16 | 2013 |
novel methods for treating cancer | 15 | 2014 |
methods for treating cancer with a stat3 pathway inhibitor and kinase inhibitor | 14 | 2015 |